Market Summary
USD25.29-0.20
Market Closed-0.78%
PRVA Stock Price
PRVA RSI Chart
PRVA Valuation
PRVA Price/Sales (Trailing)
PRVA Profitability
PRVA Fundamentals
PRVA Revenue
PRVA Earnings
Price Action
52 Week Range
20.6444.64
(Low)(High)
Last 7 days
-0.6%
Last 30 days
-4.1%
Last 90 days
-8.8%
Trailing 12 Months
9.8%
PRVA Financial Health
PRVA Investor Care
Financials for Privia Health Group
| Income Statement (Last 12 Months) | ||||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
| Revenue | 5.3% | 1,429,135,000 | 1,356,660,000 | 1,267,569,000 | 1,176,194,000 | 1,066,414,000 |
| Operating Expenses | 3.9% | 1,429,996,000 | 1,375,782,000 | 1,308,287,000 | 1,225,147,000 | 1,303,304,000 |
| S&GA Expenses | 3.2% | 20,366,000 | 19,741,000 | 18,368,000 | 17,868,000 | 24,227,000 |
| EBITDA | 60.8% | -14,804,000 | -37,759,000 | -47,835,000 | -235,775,000 | - |
| EBITDA Margin | 63.4% | -0.01 | -0.03 | -0.04 | -0.22 | - |
| Earnings Before Taxes | 109.3% | 1,726,000 | -18,580,000 | -41,513,000 | -50,325,000 | -237,901,000 |
| EBT Margin | 58.2% | -0.01 | -0.03 | -0.04 | -0.22 | - |
| Interest Expenses | 168.2% | 542,000 | -795,000 | -1,372,000 | -1,011,000 | - |
| Net Income | 278.7% | 15,343,000 | -8,585,000 | -39,823,000 | -50,562,000 | -212,666,000 |
| Net Income Margin | 79.9% | -0.01 | -0.03 | -0.04 | -0.20 | - |
| Free Cahsflow | 759.0% | 47,092,000 | 5,482,000 | 51,807,000 | 51,633,000 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
| Assets | 10.4% | 875 | 793 | 808 | 745 | 723 |
| Current Assets | 6.7% | 589 | 552 | 580 | 521 | 493 |
| Cash Equivalents | -10.6% | 311 | 348 | 317 | 292 | 316 |
| Net PPE | -8.6% | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 |
| Goodwill | 6.4% | 135 | 127 | 127 | 127 | 128 |
| Liabilities | 16.5% | 319 | 274 | 317 | 278 | 265 |
| Current Liabilities | 17.2% | 310 | 264 | 305 | 265 | 220 |
| Shareholder's Equity | 11.5% | 557 | 499 | 470 | 467 | 458 |
| Retained Earnings | 3.4% | -209 | -216 | -234 | -236 | -225 |
| Additional Paid-In Capital | 1.0% | 721 | 715 | 704 | 680 | 660 |
| Accumulated Depreciation | 7.9% | 4.00 | 4.00 | 4.00 | - | - |
| Shares Outstanding | 0.7% | 115 | 115 | 114 | 110 | 108 |
| Minority Interest | 116.7% | 43.00 | 20.00 | 21.00 | 22.00 | 23.00 |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
| Cashflow From Operations | -17.1% | 39.00 | 47.00 | 6.00 | 52.00 | 52.00 |
| Share Based Compensation | -28.9% | 48.00 | 67.00 | 83.00 | 94.00 | 278 |
| Cashflow From Investing | -23867.3% | -24.93 | -0.10 | -32.47 | -32.65 | -32.81 |
| Cashflow From Financing | 3.9% | -18.90 | -19.68 | -18.47 | -27.14 | 215 |
Risks for PRVA
What is the probability of a big loss on PRVA?
86.2%
Probability that Privia Health Group stock will be more than 20% underwater in next one year
86.2%
Probability that Privia Health Group stock will be more than 30% underwater in next one year.
67.9%
Probability that Privia Health Group stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does PRVA drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Privia Health Group was unfortunately bought at previous high price.
Drawdowns
Returns for PRVA
Cumulative Returns on PRVA
Which funds bought or sold PRVA recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-05-23 | Brookfield Corp /ON/ | reduced | -64.42 | -1,628,750 | 1,241,680 | -% |
2023-05-23 | ROYCE & ASSOCIATES LP | added | 25.97 | 929,500 | 2,678,170 | 0.03% |
2023-05-22 | AMERIPRISE FINANCIAL INC | sold off | -100 | -1,414,000 | - | -% |
2023-05-18 | JPMORGAN CHASE & CO | added | 13.61 | 1,144,000 | 4,143,000 | -% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | reduced | -21.23 | -29,000 | 674,000 | -% |
2023-05-16 | COLONY GROUP LLC | reduced | -1.8 | 311,000 | 1,917,000 | 0.03% |
2023-05-16 | JANE STREET GROUP, LLC | new | - | 358,433 | 358,433 | -% |
2023-05-16 | CASTLEARK MANAGEMENT LLC | sold off | -100 | -3,330,310 | - | -% |
2023-05-16 | SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | reduced | -39.41 | -520,447 | 1,455,320 | 0.03% |
2023-05-16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | reduced | -65.18 | -1,369,640 | 1,005,670 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Privia Health Group News
Schedule 13G FIlings of Privia Health Group
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| May 15, 2023 | durable capital partners lp | 7.9% | 9,090,909 | SC 13G | |
| May 12, 2023 | pamplona capital partners iii, l.p. | 0% | 0 | SC 13G/A | |
| Feb 14, 2023 | pamplona capital partners iii, l.p. | 15.5% | 17,741,723 | SC 13G/A | |
| Feb 14, 2023 | goldman sachs group inc | 21.7% | 24,824,660 | SC 13G/A | |
| Feb 14, 2023 | sullivan william m | 5.1% | 5,860,117 | SC 13G | |
| Apr 29, 2022 | pamplona capital partners iii, l.p. | 18.8% | 20,019,808 | SC 13G/A | |
| Apr 05, 2022 | sullivan william m | 5.9% | 6,356,713 | SC 13G | |
| Feb 14, 2022 | goldman sachs group inc | 26.4% | 28,007,452 | SC 13G | |
| Feb 14, 2022 | pamplona capital partners iii, l.p. | 18.8% | 20,019,808 | SC 13G |
PRVA Fair Value
Recent SEC filings of Privia Health Group
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| May 16, 2023 | 4 | Insider Trading | |
| May 15, 2023 | 4 | Insider Trading | |
| May 15, 2023 | SC 13G | Major Ownership Report | |
| May 12, 2023 | SC 13G/A | Major Ownership Report | |
| May 11, 2023 | 144 | Notice of Insider Sale Intent | |
| May 11, 2023 | 4 | Insider Trading | |
| May 11, 2023 | 4 | Insider Trading | |
| May 11, 2023 | 4 | Insider Trading | |
| May 11, 2023 | 4 | Insider Trading | |
| May 10, 2023 | 8-K | Current Report |
Latest Insider Trading transactions for PRVA
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-05-12 | Sullivan William M | sold | -481,781 | 26.54 | -18,153 | - |
2023-05-11 | Mehrotra Parth | acquired | 450 | 2.00 | 225 | president and coo |
2023-05-11 | Mehrotra Parth | sold | -6,300 | 28.00 | -225 | president and coo |
2023-05-09 | Sullivan William M | sold | -39,091 | 30.07 | -1,300 | - |
2023-05-09 | Bartrum Thomas | acquired | 136 | 2.00 | 68.00 | evp, general counsel |
2023-05-09 | Bartrum Thomas | sold | -2,040 | 30.00 | -68.00 | evp, general counsel |
2023-05-09 | Mehrotra Parth | acquired | - | - | 73,529 | president and coo |
2023-05-09 | Mountcastle David | acquired | - | - | 22,058 | evp & chief financial officer |
2023-05-09 | Bartrum Thomas | acquired | - | - | 18,382 | evp, general counsel |
2023-05-08 | GOLDMAN SACHS GROUP INC | sold | -536,473,000 | 21.615 | -24,819,500 | - |
Matthew S. Morris
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
PRVA Income Statement
2023-03-31Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
|---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
| Income Statement [Abstract] | ||
| Revenue | $ 386,276 | $ 313,801 |
| Operating expenses: | ||
| Provider expense | 302,255 | 242,187 |
| Cost of platform | 44,730 | 41,272 |
| Sales and marketing | 5,286 | 4,661 |
| General and administrative | 25,951 | 36,110 |
| Depreciation and amortization | 1,340 | 1,118 |
| Total operating expenses | 379,562 | 325,348 |
| Operating income (loss) | 6,714 | (11,547) |
| Interest (income) expense, net | (1,813) | 232 |
| Income (loss) before provision for income taxes | 8,527 | (11,779) |
| Provision for income taxes | 2,125 | 6,308 |
| Net income (loss) | 6,402 | (18,087) |
| Less: loss attributable to non-controlling interests | (922) | (577) |
| Net income (loss) attributable to Privia Health Group, Inc. | $ 7,324 | $ (17,510) |
| Net income (loss) per share attributable to Privia Health Group, Inc. stockholders – basic (in dollars per share) | $ 0.06 | $ (0.16) |
| Net income (loss) per share attributable to Privia Health Group, Inc. stockholders – diluted (in dollars per share) | $ 0.06 | $ (0.16) |
| Weighted average common shares outstanding - basic (in shares) | 115,009,010 | 108,059,064 |
| Weighted average common shares outstanding – diluted (in shares) | 124,328,964 | 108,059,064 |
PRVA Balance Sheet
2023-03-31Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 311,229 | $ 347,992 |
| Accounts receivable | 260,881 | 189,604 |
| Prepaid expenses and other current assets | 16,667 | 14,366 |
| Total current assets | 588,777 | 551,962 |
| Non-current assets: | ||
| Property and equipment, net | 3,095 | 3,386 |
| Right-of-use asset | 7,618 | 8,089 |
| Intangible assets, net | 97,637 | 57,387 |
| Goodwill | 135,050 | 126,938 |
| Deferred tax asset | 38,503 | 40,368 |
| Other non-current assets | 4,663 | 4,683 |
| Total non-current assets | 286,566 | 240,851 |
| Total assets | 875,343 | 792,813 |
| Current liabilities: | ||
| Accounts payable and accrued expenses | 46,300 | 52,837 |
| Provider liability | 260,368 | 208,424 |
| Operating lease liabilities, current | 3,021 | 3,013 |
| Total current liabilities | 309,689 | 264,274 |
| Non-current liabilities: | ||
| Operating lease liabilities, non-current | 7,788 | 8,490 |
| Other non-current liabilities | 1,345 | 1,000 |
| Total non-current liabilities | 9,133 | 9,490 |
| Total liabilities | 318,822 | 273,764 |
| Commitments and contingencies (Note 11) | ||
| Stockholders’ equity: | ||
| Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 115,469,961 and 114,690,808 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively | 1,159 | 1,148 |
| Additional paid-in capital | 721,486 | 714,639 |
| Accumulated deficit | (209,369) | (216,693) |
| Total Privia Health Group, Inc. stockholders’ equity | 513,276 | 499,094 |
| Non-controlling interest | 43,245 | 19,955 |
| Total stockholders’ equity | 556,521 | 519,049 |
| Total liabilities and stockholders’ equity | $ 875,343 | $ 792,813 |